Evidence map›Paper›PMID 42293570›Full record

ArticlePathology oncology research : POR2026

Proof-of-principle 4-marker spatial profiling reveals distinct, location-independent immune clusters in biliary tract cancers.

Federico Rossari, Michele Sala, Margherita Rimini, Silvia Camera, Mara Persano, Giovanni Tonon, Chiara Bonini, Maria Giulia Cangi, Lorenza Pecciarini, Claudio Doglioni and 4 more

Abstract read
In one paragraph

Article in Pathology oncology research : POR, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Federico Rossari *Department of Oncology, IRCCS San Raffaele Scientific Institute, Milan, Italy.
Michele Sala *Center for Omics Sciences, IRCCS San Raffaele Scientific Institute, Milan, Italy.
Margherita RiminiDepartment of Oncology, IRCCS San Raffaele Scientific Institute, Milan, Italy.
Silvia CameraDepartment of Oncology, IRCCS San Raffaele Scientific Institute, Milan, Italy.
Mara PersanoDepartment of Oncology, IRCCS San Raffaele Scientific Institute, Milan, Italy.
Giovanni Tonon"Vita-Salute" San Raffaele University, Milan, Italy.
Chiara Bonini"Vita-Salute" San Raffaele University, Milan, Italy.
Maria Giulia CangiPathology Unit, IRCCS San Raffaele Scientific Institute, Milan, Italy.
Lorenza PecciariniPathology Unit, IRCCS San Raffaele Scientific Institute, Milan, Italy.
Claudio Doglioni"Vita-Salute" San Raffaele University, Milan, Italy.
Maurilio Ponzoni"Vita-Salute" San Raffaele University, Milan, Italy.
Chiara Balestrieri *Center for Omics Sciences, IRCCS San Raffaele Scientific Institute, Milan, Italy.
Federica Pedica *"Vita-Salute" San Raffaele University, Milan, Italy.
Andrea Casadei-Gardini *Department of Oncology, IRCCS San Raffaele Scientific Institute, Milan, Italy.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Biliary tract cancers (BTCs) are aggressive malignancies with limited treatment options. Despite advances with durvalumab plus chemotherapy, prognosis remains poor. The tumor immune microenvironment (TIME) is increasingly recognized as a determinant of immunotherapy response, yet its spatial organization in BTC is poorly understood. We applied multiplex immunofluorescence to pre-treatment tumor samples from 11 patients with advanced BTC, staining for CD4, CD8, CD20, and CD163 to identify T cells, B cells, and macrophages. Across 198 regions of interest sampled at the invasive tumor margin, approximately 400,000 individual cells were segmented and phenotyped. Spatial organization was analyzed using hierarchical clustering, distance-based approaches, and cellular neighborhood classification. Unsupervised analysis identified two distinct immune phenotypes, one enriched in CD4

Indexed as

Biliary Tract NeoplasmsBiomarkers, TumorLymphocytes, Tumor-InfiltratingTumor MicroenvironmentAgedB-LymphocytesFemaleHumansMacrophagesMaleMiddle AgedPrognosisBiomarkers, Tumorbiliary tract cancercholangiocarcinomaimmunofluorescenceimmunotherapytumor microenvironment

Identifiers

PMID42293570
PMCPMC13253487

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.